A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
PHASE2
This is a 6-week, randomised, multicenter, double-blind, placebo controlled...